Best of 2022: Myths & Misconceptions with Febrile Disorders
Editor’s note: this blog originally appeared July 12, 2022, and is being shared again…
View Resource
CBT or Naltrexone in Fibromyalgia (12.8.2023)
Dr. Jack Cush reviews the news and journal articles from the past week on…
View Resource
All in the Family (8.23.2024)
Dr. Jack Cush picks highlight reports from the past week on RheumNow.com, with reports…
View Resource
Infection or Disease Flare: What Tools Can Help Differentiate?
Differentiation between a flare of disease and infection in patients with autoinflammatory (AI) conditions,…
View Resource
Fever Pitch (7.15.2022)
Dr. Jack Cush reviews the new studies and drug approvals and new insights into…
View Resource
Solving Still's Disease
Still’s disease is the most common rheumatic cause of unknown fever in adults. This…
View Resource
Best of 2022: Five Mistakes When Diagnosing Still’s Disease
Editor’s note: this blog originally published on July 6, 2022, and is being shared…
View Resource
ICYMI: Here at Last: Treatment Options for VEXAS
We have known about the VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome for…
View Resource
Running with Data (8.30.2024)
Dr. Jack Cush reviews the news and journal reports from the past week on…
View Resource
JAK Inhibitors in Refractory Adult and Childhood-Onset Still’s Disease
Still’s disease is an autoinflammatory disease characterized by spiking fever, rash, polyarthralgia, sore throat…
View Resource